Rajarsi Mandal

6PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 20, 2026
Calculating Glucagon-Like Pepide-1 Receptor Agonist-Associated Medullary Thyroid Cancer Risk: A Novel Integration of the Surveillance, Epidemiology and End Results Cancer Registry and the FDA Adverse Event Reporting System.

|Dec 03, 2024
Methodology of cfHPV-DNA Detection in Head and Neck Cancer: A Systematic Review and Meta-analysis.

Jerin Thomas, Eden Mazzara, Meytal Guller

|Dec 20, 2023
Allergy History and Immunotherapy Response in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

Hosam H Alkhatib, Christopher A Maroun, Meytal Guller

|Oct 05, 2022
Node Count as a Quality Indicator in Surgically Treated Mucosal Head and Neck Squamous Cell Cancer.

Joseph Lopez, Maria Laura Reategui, Lisa Rooper

|May 31, 2022
Surgeon Volume and Laryngectomy Outcomes.

Anirudh Saraswathula, J Matthew Austin, Carole Fakhry

|May 04, 2019
Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response.

Rajarsi Mandal, Robert M Samstein, Ken-Wing Lee

Pageof 1

Frequent Collaborators

2 joint publications

Christine G Gourin

1 joint publications

Robert M Samstein

1 joint publications

Ken-Wing Lee

1 joint publications

Jonathan J Havel